Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis-Reference-Cited by-同舟云学术

Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis

Published:2013-08 Issue:8 Volume:8 Page:1050-1058
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Guckenberger Matthias,Allgäuer Michael,Appold Steffen,Dieckmann Karin,Ernst Iris,Ganswindt Ute,Holy Richard,Nestle Ursula,Nevinny-Stickel Meinhard,Semrau Sabine,Sterzing Florian,Wittig Andrea,Andratschke Nicolaus

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005

2. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009

3. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009

4. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial;Ricardi;Lung Cancer,2010

5. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective study;The Lancet Regional Health - Europe;2024-09

2. Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience;Clinical and Translational Radiation Oncology;2024-03

3. Hypofractionation for Lung Tumors (Primary Malignant, Secondary Malignant);Hypofractionated and Stereotactic Radiation Therapy;2024

4. Multicentric development and evaluation of [18F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy;European Journal of Nuclear Medicine and Molecular Imaging;2023-11-21

5. Stereotactic body radiation therapy in unresectable stage III non-small cell lung cancer: A systematic review;Cancer Treatment Reviews;2023-07